학술논문
An open-label phase 2a study investigating the efficacy and safety of a cathepsin S inhibitor in patients with moderate-to-severe psoriasis.
Document Type
journal article
Source
Journal of the American Academy of Dermatology; Nov2022, Vol. 87 Issue 5, p1089-1091, 3p
Subject
Language
ISSN
01909622